17. Order attached I Read full article » Cancer Biotech Oasmia Hid Deals From Investors, Suit Says Investors for Swedish cancer biotechnology firm Oasmia launched a proposed class action lawsuit in New York federal court Monday, alleging the company actively concealed a number of deals involving enti